Trading Summary - Week August 5-9. Another excellent

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
463
Trading Summary - Week August 5-9.

Another excellent week for $EVSV with further updates about the excellent progress being made with hemp production, large investor interest, the reverse merger and future partnerships + the 2019 Q2 coming out on time with a detailed description of the company's new business model since the merger.

$EVSV remained in the range .6250 > .7500 all week - compared to .6346 > .6800 last week.

Only those that bid .6800 or hit the ask above that were able to buy any significant amount.

There were visible bidders in depth at various points from .6000 > .6800 all week.

Overall, 35,436 shares were bought this week - 5 x the amount the previous week primarily due to those that were willing to buy at realistic prices .6800 or above.

$EVSV has now held above the r/s par of .4000 for 6 months 3 weeks - currently 62.5% up.

Those waiting to load "just-in-time" for the move might like to consider buying in the .6800 > .9999 range while they still can - updates are likely to be coming out every few days now on the hemp production at the first of many sites (now confirmed as harvesting in mid-Sep ) and new partnerships / major investors.

$EVSV remains the #3 Pick on the Watch List for profit earning potential in 2019 - out-trumped only by and $VYST - which will offer $500K > $1M+ profits if the NASDAQ requirement price is met [trading discipline and patience required] and $TMPS which had a DoD contract awarded that was 4 x the size I was expecting ($121M) when I originally ranked the picks for 2019.

As previously stated, the top traders in $EVSV are not going to waste our time playing in among the manipulation action apart from taking out asks when it suits us and maintaining a basher / flipper reload denial bid.

Expect continued loading - now more overtly - with a mixture of hidden bids, visible larger / higher bids and ask hits - until the main traders in this are ready to move it up a bound or so - above .$1.000.

This will remain the main board for analysis of trading action. I will make occasional posts on iHub to debunk nonsense and keep the correct analysis in my single Mod sticky and 1 > 3 Plus 1 slots.

I will be updating the DD / Rolling Brief over the weekend - plus keeping an eye out for any updates from WI and FL on hemp or new partnerships.


Items below the line unchanged from previous report [except for prices moved upwards] and still valid [important points emphasized in bold]:

The 2018 Annual Report was filed on time with improved financials.

The 2019 Q1 Report was also filed within the extension timescale - key extracts here:

https://investorshangout.com/post/view?id=5443768

As usual, the TA updated the share structure in a timely manner as at July 29, 2019 - yet again confirming no dilution.

Don't expect any significant amount to be offered under $1.000 as it is not unreasonable to expect to see $1 to $2 at some point in 2019 based on the thin share structure, the majority of shares being in the hands of savvy traders , and multiple catalysts ahead.

There is still very little in asks under $1.000 and $EVSV should be extremely thin well into the $1 > $2 range based on who had what where prior to the r/s.

Any one of the significant traders in $EVSV could move it to 1.000 single handed if they chose to. I might do it myself just to deny the cheap shares to the basher / manipulators on a day that is relatively inactive on my other top picks.

There are now more than 109 x social media alerters / analysts that have $EVSV on their radar now for continued upward movement - as listed here (updated figures coming this weekend):

Overall, $EVSV continues to play out exactly as I expected and suggested it would for those following my proven "trading through a r/s" strategy.

Ahead expect:

- Continued manual and further automatic outbidding.

- Closing of the spread and / or hitting the ask across a wide spread when an artificially low fake ask is seen.

- More hits on the ask.

- Further updates on the progress of entry into the hemp sector - particularly in the other 6 states being considered - as one of the company's diversification efforts.

- Further updates on a share buyback by the company.

- Further updates on new partnerships.

- Update to the share structure by August 31, 2019.

- Further updates to the Hemp Division website.





Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dermatology Access Expands in Kansas With Expert Return

Updated Category News Views 23

Jenna King's Return Elevates Local Care Who says you can't go home again? Jenna King, a familiar face in Southeast Kansas, is back to serve her community by upping the ante in dermatology care at U.S. Dermatology Partners in Pittsburg. After gaining experience in Oklahoma, she's here to extend both medical and cosmetic treatments to her neighbors. Why Her Return Is a Game...

Continue Reading
Direxion Targets Anthropic's IPO with Bold New ETFs

Updated Category News Views 40

Anthropic's IPO Sparks Direxion's Latest ETF Moves Alright, folks, Anthropic's public filing for an IPO isn't just turning heads—it's lighting up the trading floor! Following this buzz, Direxion grabs its chance to unleash two new ETFs designed to seize on Anthropic's rollercoaster debut. We're talking about the Direxion Daily Anthropic Bull 2X ETF (ANTO) and the...

Continue Reading
Aker BP's Q3 2026: Strong Earnings Fuel Optimism

Updated Category News Views 126

Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...

Continue Reading
Entangled 2026 Summit: Driving Quantum, AI, & Biotech Synergy

Updated Category News Views 36

What's Brewing at Entangled 2026? Innovation's got a new haunt come November, and it’s sprouting right in Cambridge's Kendall Square. LabCentral, C10 Labs, and Innovation Centre Denmark Boston have concocted something here for the curious minds: Entangled 2026. Picture over 250 movers and shakers from biotech, deep tech, investment, academia, and more, gathering under...

Continue Reading
Pozdeutinurad Phase 3 Success Impact on Sobi and Market

Updated Category News Views 70

Pozdeutinurad's Phase 3 Triumph Ah, the life of biotech—constant ups and downs, but when you hit a homerun, it feels like the market stands still for a second. Pozdeutinurad's recent Phase 3 REDUCE-2 study results are one of those moments for Swedish Orphan Biovitrum AB, or Sobi for short. This study showed some seriously compelling data: clinically meaningful and...

Continue Reading
P.S. Active Teams with Barrett for Logistics Boost

Updated Category News Views 9

Barrett Gets in the Game with P.S. Active Alright, picture this: an activewear brand hooked up with a logistics heavyweight. No, it's not just another round of corporate muscle-flexing—it's P.S. Active, spearheaded by Erika Hammond, partnering with Barrett Distribution Centers to elevate their fulfillment game from New Jersey's Somerset hub. The Stakes: More Than Just...

Continue Reading
Fan Creations Shine: McLaren's Unique Livery Unveiled

Updated Category News Views 98

From Sticker Dreams to Racing Reality Some days bring surprises outside the typical ticker watch as those market charts get shoved aside, right when fans' stories race onto the scene. What McLaren and Velo cooked up for the Mexico City Grand Prix has got me pausing—a blend of motorsport passion and grassroots creativity. By unveiling the 'Livery of Dreams,' McLaren puts...

Continue Reading
ServiceNow Faces Legal Probe Amid Stock Slide

Updated Category News Views 52

Stock Turbulence Hits ServiceNow Investors Wake up and smell the market correction! ServiceNow's done slapped its shareholders with a situation no one saw coming—or maybe not. When the market opened on October 29, NYSE:NOW shares weren't just dipping; they were diving off a $29 cliff, all thanks to some sour guidance for fourth-quarter growth. Talk about financial...

Continue Reading
Cat Financial Shows Solid Q3 Growth Amid Challenges

Updated Category News Views 82

Healthy Gains in Revenues and Profits Well, Cat Financial's latest report is another piece of the puzzle showing steady, if not spectacular, growth. They've jacked up their revenues by 10% for the third quarter of 2026 compared to last year's same stretch. This puts the revenues at $1.02 billion, a $95 million bump from the previous year. Pretty impressive. The profit saw...

Continue Reading
Busch Gardens' Holiday Extravaganza Lights Up 2026

Updated Category News Views 30

A Dazzling Holiday Transformation Awaits Forget the mundane holiday light displays. Busch Gardens is cranking it up a notch with their annual Christmas Town spectacle, kicking off on November 13. With two parks—Tampa Bay and Williamsburg—each delivering a unique experience, prepare for an immersive dive into holiday cheer that's packed with glitz, entertainment, and,...

Continue Reading

Top 5 Most Recently Viewed Articles

PharmaTher's Bold Plans for Ketamine Market Domination

Updated Category News Views 127

PharmaTher's Roadmap to Ketamine Commercialization PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a pioneering specialty pharmaceutical firm, is steering its focus towards the development and commercialization of ketamine-based therapies. The Company has carved out an impressive path for itself as it aspires to lead in unlocking the...

Continue Reading
Causum's Mars® Emerges as Key AI Governance Tool for Firms

Updated Category News Views 175

The Rise of AI Governance in a Chaotic Landscape Here we are, on the cusp of a tech revolution where regulations are starting to tighten around AI like a vise. You remember those wild days back during the dot-com boom, right? Everyone was scrambling to cash in on tech, while the ground rules were still being drawn up. Well, history's repeating itself—only this time,...

Continue Reading
Parsons Corporation to Share Insights at Key Financial Conference

Updated Category News Views 309

Parsons Corporation's Upcoming Conference Presentation Parsons Corporation will soon take the stage at a significant financial event known as the Raymond James 46th Annual Institutional Investors Conference. This prestigious conference is an excellent opportunity for the company to engage with investors and provide insights into its strategic direction. Featured Speakers...

Continue Reading
Innovative Mud Cleaning Tool Revolutionizes Home Renovations

Updated Category News Views 213

Revolutionizing Mud Pan Cleaning with Innovative Design Meet a groundbreaking solution for home renovation enthusiasts and professionals alike—an inventive tool designed specifically for cleaning mud pans efficiently and effectively. This innovative product stems from the extensive experience of a skilled drywall finisher who spent 40 years in the industry, identifying...

Continue Reading
Brookfield Asset Management Achieves New Heights with BAM Stock

Updated Category News Views 108

Brookfield Asset Management Achieves New Heights with BAM Stock Brookfield Asset Management Inc (TSX: BAM) recently celebrated a major milestone as its stock reached an impressive 52-week high of $47.45. This achievement demonstrates the company’s strong growth trajectory and effective strategies in place. Investors are showing increased confidence in BAM’s unique...

Continue Reading